Bayer's Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"

Creator

Piorkowski, Joseph D., Jr.

Bibliographic Citation

JAMA: The Journal of the American Medical Association 2004 December 1; 292(21): 2655-2657

Permanent Link

Find in a Library.
Full Text from Publisher
http://hdl.handle.net/10822/986253

Date

2004-12-01

Subject

Conflict of Interest; Evaluation; Risk; Professional-Professional Relationship; Drugs and Drug Industry; Scientific Research Ethics;

Collections

EthxWeb: Literature in Bioethics

Metadata

Show full item record